Zobrazeno 1 - 10
of 127
pro vyhledávání: '"and E. A. Ponomarev"'
Autor:
P. D. Tretyakov, E. I. Ponomarev
Publikováno v:
Сибирский лесной журнал, Vol 10, Iss 6, Pp 17-31 (2023)
The dynamics of vegetation fires on the territory of the Arctic zone of Siberia (64–74°N, 60–150°E) was studied under the conditions of observed climatic changes at the turn of the XX – beginning of the XXI centuries. In the study area, four
Externí odkaz:
https://doaj.org/article/37e54f8fbaff43329de5f795cb47dc21
Autor:
S. V. Shkodkin, M. Z. A. A. Zubaidi, V. P. Bondarev, M. B. Chibichyan, E. G. Ponomarev, V. Yu. Nechiporenko, K. S. Shkodkin
Publikováno v:
Вестник урологии, Vol 11, Iss 4, Pp 108-119 (2023)
Introduction. Nephron-sparing surgery for localised renal cell carcinoma has firmly entered the guideline base of all urological associations. One important aspect of this surgery is the management of the renal wound after partial nephrectomy. The ab
Externí odkaz:
https://doaj.org/article/9e47d75ee15c49d09ca73eb2791799ca
Autor:
S. V. Shkodkin, Yu. B. Idashkin, M. Z. A. A. Zubaidi, A. D. Kravets, A. F. Khuseinzoda, Zh. K. Askari, E. G. Ponomarev, V. Y. Nechiporenko, K. S. Shkodkin
Publikováno v:
Вестник урологии, Vol 10, Iss 3, Pp 74-83 (2022)
Introduction. Partial nephrectomy occupies a rightful priority position in the treatment of localized renal cell carcinoma. It not only provides high oncological results but also allows you to save the renal parenchyma. This reduces the risk of chron
Externí odkaz:
https://doaj.org/article/4a9abb28006a43d788d17fdffe3fe8c3
Autor:
S. V. Shkodkin, Yu. B. Idashkin, M. Z. A. A. Zubaidi, A. D. Kravets, A. F. Khuseinzoda, Zh. K. Askari, E. G. Ponomarev, V. Y. Nechiporenko, K. S. Shkodkin
Publikováno v:
Вестник урологии, Vol 10, Iss 3, Pp 122-132 (2022)
Introduction. A century and a half of experience in renal surgery has shown the clinical feasibility of preserving a functioning renal parenchyma and the pathogenetic validity of nephron-sparing surgery (NSS) in renal cell carcinoma (RCC).Objective.
Externí odkaz:
https://doaj.org/article/7bf401ce651e473c812f52bfd31bd1b5
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 3, Pp 84-89 (2022)
Introduction. The low solubility of active pharmaceutical ingredients (APIs) in the physiological pH range of the intestinal tract can adversely affect their absorption and bioavailability. Various methods of increasing the solubility of APIs have be
Externí odkaz:
https://doaj.org/article/a5b958ab2e7545709a97d65538905197
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 2, Pp 87-93 (2022)
Introduction. Many of new active pharmaceutical ingredients (APIs) have low solubility that can affect bioavailability negatively and therefore therapeutically efficacy as well. These APIs include the following antiretroviral substances: ritonavir, e
Externí odkaz:
https://doaj.org/article/329d331b33f345efa62c97a06ab8a58d
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 4, Pp 28-35 (2021)
Introduction. Etravirine, being one of the most popular antiretroviral drugs, doesn't have its physicochemical properties sufficiently described in scientific publications. Detailed information on the substance properties is necessary both for organi
Externí odkaz:
https://doaj.org/article/6683c065752944b4a33e3410217a2a3a
Autor:
E. G. Ponomarev
Publikováno v:
Гуманитарные и юридические исследования, Vol 0, Iss 1, Pp 100-105 (2021)
RETRACTED ARTICLEThe article highlights the foundation of parliamentary reform of the Russian Empire laid by the Highest rescript of February 18, 1905, which was signed by Nicholas II. The author analyzes a complex process of discussion and establish
Externí odkaz:
https://doaj.org/article/6537f6b4607742488cef8991504dc636
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 1, Pp 67-73 (2021)
Introduction. Usage of aggressive conditions (solvents, high temperature, etc.) in a dosage form manufacturing can lead to a change in the properties of a pharmaceutical substance. Darunavir (D) amorphous and darunavir ethanolate (DE) crystalline bot
Externí odkaz:
https://doaj.org/article/fd3f60cf041542e9964980364c6b9841
Autor:
V. A. Markov, D. V. Duplyakov, S. L. Konstantinov, G. V. Klein, S. B. Aksentev, D. Yu. Platonov, E. V. Vyshlov, E. A. Ponomarev, R. M. Rabinovich, E. L. Makarov, E. V. Kulibaba, D. S. Yunevich, O. V. Kritskaia, E. A. Baranov, O. B. Talibov, E. A. Gerasimets
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 11, Pp 110-116 (2018)
Aim. Evaluate the oneyear results and clinical outcomes of a multicenter randomized clinical trial FRIDOM1.Material and methods. The study FRIDOM1 was conducted in 11 clinical centers of the Russian Federation in the period 20142016. The study
Externí odkaz:
https://doaj.org/article/d356e98be2464985907eb248a4d50606